Lumos Pharma Corp - Aset Bersih saben Siji Saham LUMO

Lumos Pharma, Inc. (LUMO) develops convenient oral medications for children with hormonal deficiencies. The trust of geneticists confirms the value of these innovations, and on GURU.Markets, the book value per share trend clearly links market potential with brand reputation. The current 0.57 metric determines the parameter status, while the R&D stage and rising research costs temporarily limit business scaling.

Lumos Pharma Inc (LUMO): Nilai Buku Saham saka 04.07.2022 nganti 21.12.2024

lumos-pharma.com - rincian analitis lan metrik utama (LUMO)

- rega lan prakiraan konsensus rega:

Bagan rega Lumos Pharma Corp|LUMO - Target konsensus

- data kapitalisasi pasar:

Nilai pasar Lumos Pharma, Inc.|LUMO - Total Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Lumos Pharma|LUMO - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku lumos-pharma.com|LUMO - Nilai Agregat Aset

- data utang lan likuiditas:

Total Utang marang Modal Lumos Pharma, Inc.|LUMO - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Lumos Pharma|LUMO - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Lumos Pharma, Inc.|LUMO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Lumos Pharma

Pambiji fundamental perusahaan:Lumos Pharma Corp - LUMO

Book value per share allows investors to filter out market volatility by measuring the company's net equity minus all liabilities to assess the business's intrinsic stability. By analyzing the historical trend of the book value per share, an investor can discern the actual volume of assets held by Lumos Pharma (LUMO), the reliability of which is bolstered by diversified raw material supply chains that guarantee the continuity of drug development for metabolic disorders.

Pesaing Lumos Pharma, Inc. (LUMO)